Centene (NYSE:CNC – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 6.800- for the period, compared to the consensus EPS estimate of 6.820. The company issued revenue guidance of $159.0 billion-$161.0 billion, compared to the consensus revenue estimate of $155.6 billion.
Wall Street Analysts Forecast Growth
Several research firms have commented on CNC. Stephens restated an “equal weight” rating and issued a $78.00 target price on shares of Centene in a report on Monday, August 5th. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a report on Monday. Truist Financial lowered their target price on shares of Centene from $92.00 to $89.00 and set a “buy” rating for the company in a report on Monday, July 15th. Cantor Fitzgerald reiterated an “overweight” rating and set a $90.00 price objective on shares of Centene in a report on Tuesday, October 1st. Finally, Sanford C. Bernstein decreased their price objective on shares of Centene from $96.00 to $88.00 and set an “outperform” rating for the company in a report on Wednesday. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Centene has a consensus rating of “Moderate Buy” and an average target price of $84.00.
Centene Stock Up 1.9 %
Centene Company Profile
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Read More
- Five stocks we like better than Centene
- How to Invest in Small Cap StocksĀ
- Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
- Stock Splits, Do They Really Impact Investors?
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.